Loading...

Follow Kidney Cancer Support Network on Feedspot

Continue with Google
Continue with Facebook
or

Valid

Please get behind Steve to support him during his 40 days of fitness before he turns 40! All donations will help support KCSN and The ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Further data from the TIVO-3 clinical trial comparing tivozanib with sorafenib in patients with advanced renal cell carcinoma (RCC), which ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

A recent study published in Clinical Cancer Research analysed tumour tissue samples obtained in a clinical trial to investigate how the ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Immune checkpoint inhibitors, such as nivolumab, ipilimumab or pembrolizumab are often used alone or in combination with other drugs for ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

A recent study has provided evidence that a subset of patients with metastatic renal cell carcinoma (RCC) may be observed safely without ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

A combination of ilixadencel plus sunitinib has shown a complete tumour response in patients with metastatic renal cell carcinoma (RCC) in ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

The 2018 NHS Cancer Patient Experience Survey showed that nine out of ten patients are happy with the care and support they’ve received ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

In this video interview, Dr David Braun from the Dana-Farber Cancer Institute in Boston, USA, discusses his innovative research in ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Based on the findings from the pivotal phase 3 KEYNOTE-426 trial, the European Commission has today approved pembrolizumab (anti-PD-1 ..read more
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

The NHS has announced that it has saved more than £700 million from the annual medicines bill to reinvest in new treatments, as part of ..read more

Read for later

Articles marked as Favorite are saved for later viewing.
close
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Separate tags by commas
To access this feature, please upgrade your account.
Start your free month
Free Preview